DONCINAT

This brand name is authorized in Nigeria.

Active ingredients

The drug DONCINAT contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-6907	Tablet	Doncinat 500 Tablets TAB 500 mg	Each tablet contains: Cefuroxime Axetil equiv. to Cefuroxime 500 mg	20/12/2019
B4-1309	Powder for suspension	Doncinat 125 Powder for Oral Suspension PWD_F_SOL 125 mg/5 mL	Powder for Reconstitution Each 5 mL suspension contains: Cefuroxime Axetil equiv. to Cefuroxime 125 mg	20/12/2019

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-6907, B4-1309